A Multimodal Omics Framework to Empower Target Discovery for Cardiovascular Regeneration

Cardiovasc Drugs Ther. 2024 Apr;38(2):223-236. doi: 10.1007/s10557-023-07484-7. Epub 2023 Jul 8.

Abstract

Ischaemic heart disease is a global healthcare challenge with high morbidity and mortality. Early revascularisation in acute myocardial infarction has improved survival; however, limited regenerative capacity and microvascular dysfunction often lead to impaired function and the development of heart failure. New mechanistic insights are required to identify robust targets for the development of novel strategies to promote regeneration. Single-cell RNA sequencing (scRNA-seq) has enabled profiling and analysis of the transcriptomes of individual cells at high resolution. Applications of scRNA-seq have generated single-cell atlases for multiple species, revealed distinct cellular compositions for different regions of the heart, and defined multiple mechanisms involved in myocardial injury-induced regeneration. In this review, we summarise findings from studies of healthy and injured hearts in multiple species and spanning different developmental stages. Based on this transformative technology, we propose a multi-species, multi-omics, meta-analysis framework to drive the discovery of new targets to promote cardiovascular regeneration.

Keywords: Cardiovascular regeneration; Heart failure; Myocardial infarction; Single-cell RNA sequencing; Target discovery.

Publication types

  • Review

MeSH terms

  • Heart
  • Heart Failure*
  • Humans
  • Myocardial Infarction* / genetics
  • Myocardial Ischemia*
  • Regeneration